Aralez and CAAIF Research Grant in Allergic Rhinitis or Urticaria

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire with Unit

Memorial Deadline: Monday 25th, February 2019

External Deadline: Thursday 28th, February 2019


The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable organization,
established to increase educational opportunities and research resources for the Canadian Allergy and Immunology community. This grant is focused on the study of allergic rhinitis or urticaria and will provide one grant of $50,000. The CAAIF Research Committee will oversee the application review process.

The goal of the Foundation is not to replace larger granting bodies who fund allergy and/or immunology research. Due to the limited nature of our funds, the competition may be a means of securing seed or supplemental funding for larger projects or to initiate an innovative project idea that requires preliminary data before a larger grant application can be made. Projects that are more appropriately aimed at the pharmaceutical industry directly will not be considered.

About Aralez
Aralez Pharmaceuticals Canada Inc. is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products primarily in allergy, dermatology and other specialty areas.

Please forward your complete application assembled into one PDF file via email by
February 28, 2019 at 11:00 pm in the time zone of the applicant to 


Aralez and CAAIF Research Grant in Allergic Rhinitis or Urticaria RFA

Funding Sources

Aralez Pharmaceuticals Canada Inc.
Canadian Asthma, Allergy and Immunology Foundation

This opportunity was posted by: RGCS

Last modified: January 10, 2019